Lack of Hormonal Changes in Postmenopausal Women of Equal Weight with and Without Osteoporosis, Including Relation to Time of Menopause

Overview

Journal Clin Rheumatol

Publisher Springer

Specialty Rheumatology

Date 1984 Sep 1

PMID 6488712

Citations 1

Authors

H Rico

A Charro

I Depablos

E Bordiu

E R Hernandez

D Espinos

Affiliations

Soon will be listed here.

Abstract

The hormonal variations in postmenopausal osteoporosis are not precisely defined. The duration of the menopause and other factors, such as the weight of the patients, may be of significance. Having a basic criterion of uniformity in weight, sixty postmenopausal women were studied in regard to the following aspects: urinary hydroxyproline, estrone, estradiol, parathyroid hormone, thyroxine, triiodothyronine, thyroid stimulating hormone, cortisol and metacarpal cortical area/total area. They were divided into: Group A: 15 patients with osteoporosis and five years since menopause; Group B: 15 patients without osteoporosis (age-matched with group A); Group C: 15 patients with osteoporosis and more than ten years since menopause; and Group D: 15 patients without osteoporosis (age-matched with Group C). In the group with postmenopausal osteoporosis (A and C) there is a significant increase in urinary hydroxyproline/creatinine and a significant decrease of the cortical area/total area when we compared them with age-matched groups. The hormonal values do not vary significantly among the four groups. Ours results indicate an increase of bone resorption as a cause of postmenopausal osteoporosis. The hormonal variations, if any, cannot be related to basal values.

Citing Articles

Total and regional bone mineral content in women treated with GnRH agonists.

Rico H, Arnanz F, Revilla M, Perera S, Iritia M, Villa L Calcif Tissue Int. 1993; 52(5):354-7.

PMID: 8504372 DOI: 10.1007/BF00310198.

References

LAFFERTY F, SPENCER Jr G, Pearson O . EFFECTS OF ANDROGENS, ESTROGENS AND HIGH CALCIUM INTAKES ON BONE FORMATION AND RESORPTION IN OSTEOPOROSIS. Am J Med. 1964; 36:514-28. DOI: 10.1016/0002-9343(64)90100-7. View

MEEMA H, BUNKER M, MEEMA S . LOSS OF COMPACT BONE DUE TO MENOPAUSE. Obstet Gynecol. 1965; 26:333-43. View

Fucik R, Kukreja S, HARGIS G, BOWSER E, Henderson W, Williams G . Effect of glucocorticoids on function of the parathyroid glands in man. J Clin Endocrinol Metab. 1975; 40(1):152-5. DOI: 10.1210/jcem-40-1-152. View

Rico Lenza H, del Rio Vazquez A, Lozano Tonkin C, Ciguenza Gabriel R, Espinos Perez D . [Parameters of bone mass in the normal Spanish population]. Rev Clin Esp. 1978; 148(5):475-8. View

Rico H, Cabranes J, Paniagua M, de Frutos E, de Pablos I, Gomez-Castresana F . [Is phosphodiesterase responsible for bone changes in thyroid dysfunction?]. Med Clin (Barc). 1983; 81(16):702-4. View

Harris W, Heaney R . Skeletal renewal and metabolic bone disease. N Engl J Med. 1969; 280(4):193-202 contd. DOI: 10.1056/NEJM196901232800405. View

Aitken J, Hart D, Anderson J, Lindsay R, Smith D, SPEIRS C . Osteoporosis after oophorectomy for non-malignant disease in premenopausal women. Br Med J. 1973; 2(5862):325-8. PMC: 1589320. DOI: 10.1136/bmj.2.5862.325. View

Taggart H, Chesnut 3rd C, Ivey J, Baylink D, Sisom K, Huber M . Deficient calcitonin response to calcium stimulation in postmenopausal osteoporosis?. Lancet. 1982; 1(8270):475-8. DOI: 10.1016/s0140-6736(82)91451-9. View

Manolagas S, Anderson D, Lindsay R . Adrenal steroids and the development of osteoporosis in oophorectomised women. Lancet. 1979; 2(8143):597-600. DOI: 10.1016/s0140-6736(79)91663-5. View

10.

Whyte M, Bergfeld M, Murphy W, Avioli L, Teitelbaum S . Postmenopausal osteoporosis. A heterogeneous disorder as assessed by histomorphometric analysis of Iliac crest bone from untreated patients. Am J Med. 1982; 72(2):193-202. DOI: 10.1016/0002-9343(82)90810-5. View

11.

KATZ F, Kappas A . Influence of estradiol and estriol on urinary excretion of hydroxyproline in man. J Lab Clin Med. 1968; 71(1):65-74. View

12.

Delmas P, Wahner H, Mann K, Riggs B . Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein. J Lab Clin Med. 1983; 102(4):470-6. View

13.

Nordin B, Aaron J, Speed R, Crilly R . Bone formation and resorption as the determinants of trabecular bone volume in postmenopausal osteoporosis. Lancet. 1981; 2(8241):277-9. DOI: 10.1016/s0140-6736(81)90526-2. View

14.

Horsman A, Simpson M . The measurement of sequential changes in cortical bone geometry. Br J Radiol. 1975; 48(570):471-6. DOI: 10.1259/0007-1285-48-570-470. View

15.

Rico H, Rio A, Vila T, Patino R, Carrera F, Espinos D . The role of growth hormone in the pathogenesis of postmenopausal osteoporosis. Arch Intern Med. 1979; 139(11):1263-5. View

16.

Stevenson J, Abeyasekera G, Hillyard C, Phang K, MacIntyre I, Campbell S . Regulation of calcium-regulating hormones by exogenous sex steroids in early postmenopause. Eur J Clin Invest. 1983; 13(6):481-7. DOI: 10.1111/j.1365-2362.1983.tb00133.x. View

17.

Schindler A, Ebert A, Friedrich E . Conversion of androstenedione to estrone by human tissue. J Clin Endocrinol Metab. 1972; 35(4):627-30. DOI: 10.1210/jcem-35-4-627. View

18.

Horsman A, Simpson M, Kirby P, Nordin B . Non-linear bone loss in oophorectomized women. Br J Radiol. 1977; 50(595):504-7. DOI: 10.1259/0007-1285-50-595-504. View

19.

Berlyne G, Ben-Ari J, Kushelevsky A, Idelman A, GALINSKY D, Hirsch M . The aetiology of senile osteoporosis: secondary hyperparathyroidism due to renal failure. Q J Med. 1975; 44(175):505-21. View

20.

Riggs B, Jowsey J, Kelly P, Arnaud C . Role of hormonal factors in the pathogenesis of postmenopausal osteoporosis. Isr J Med Sci. 1976; 12(7):615-9. View